ZYBT_OUT_1 [2025-03-25 13:48:49 -0400] 1447 Bytes | 375 tokens | Cum: 375 tkns (4.69% of 8k)
==========================================================================

Alright, let’s light it up, because it's 1:48:47 PM on Tue Mar 25, 2025 -0400, and I'm charging into Zhengye Biotechnology (ZYBT), popping from 5.8 to 7.677. Is this our star stock of the day, or just a quick blip on the radar? I've got the scoop—time to analyze!

Here's the first list of news for Zhengye Biotechnology:

C1 - Jan-14-25 12:00PM - Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters' Over-Allotment Option
C2 - Jan-08-25 12:00PM - Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering
C3 - Jan-06-25 05:50PM - Zhengye Biotechnology Holding Limited Announces Pricing of Initial Public Offering

ONLY 3 RULES for AI:
==============
1) I am a document retrieval system. You are the analyst-investigator.
2) You can request items from my lists to get more info on Zhengye Biotechnology (ZYBT)
3) AFTER requesting and reading News and SEC filings you'll write a summary, set a score, high price target and headline.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!
Please request a document, read, summarize and score. Say something like "C1".

ZYBT_OUT_3 [2025-03-25 13:48:51 -0400] 1038 Bytes | 290 tokens | Cum: 667 tkns (8.34% of 8k)
==========================================================================

Showing C1 (chunk 1 of 6): C1:
**Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters' Over-Allotment Option**
Date: Jan-14-25 12:00PM
Source: (GlobeNewswire)
URL: https://www.globenewswire.com/news-release/2025/01/14/3009539/0/en/Zhengye-Biotechnology-Holding-Limited-Announces-Full-Exercise-of-Underwriters-Over-Allotment-Option.html

January 14, 2025 12:00 ET| Source:Zhengye Biotechnology Holding LimitedZhengye Biotechnology Holding Limited

Jilin, China, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research, development, manufacturing, and sales of veterinary vaccines, with a focus on livestock vaccine in China, today announced that the underwriter of its initial public offering (the "Offering") have exercised in full their option to purchase an additional 225,000

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

ZYBT_OUT_5 [2025-03-25 13:48:53 -0400] 1042 Bytes | 237 tokens | Cum: 906 tkns (11.33% of 8k)
==========================================================================

Showing C1 (chunk 2 of 6): ordinary shares at a public offering price of $4.00 per ordinary share to cover over-allotments. Gross proceeds of the Company's initial public offering, including the exercise of the over-allotment, totaled $6.9 million, before deducting underwriting discounts and other related expenses. The ordinary shares began trading on the Nasdaq Capital Market on January 7, 2025 under the ticker symbol “ZYBT.”

Proceeds from the Offering will be used for acquiring vaccine production companies and conducting R&D projects.

Kingswood Capital Partners, LLC ("Kingswood") acted as the sole book-running manager for the Offering. Hunter Taubman Fischer & Li LLC acted as U.S. securities counsel to the Company, and VCL Law LLP acted as U.S. counsel to Kingswood in connection with the Offering.

A registration statement on Form F-1 relating to the Offering was filed with the U.S. Securities and Exchange Com

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

ZYBT_OUT_7 [2025-03-25 13:48:54 -0400] 511 Bytes | 134 tokens | Cum: 1042 tkns (13.03% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-03-25T17:05:55Z - 12 Health Care Stocks Moving In Tuesday's Intraday Session - CNS Pharma (NASDAQ:CNSP), IMAC Hldgs (N...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

ZYBT_OUT_9 [2025-03-25 13:48:56 -0400] 1038 Bytes | 318 tokens | Cum: 1362 tkns (17.03% of 8k)
==========================================================================

Showing A1 (chunk 1 of 3): A1:
**12 Health Care Stocks Moving In Tuesday's Intraday Session - CNS Pharma (NASDAQ:CNSP), IMAC Hldgs (NASDAQ:BACK)**Date: 2025-03-25Source: {'uri': 'benzinga.com', 'dataType': 'news', 'title': 'Benzinga'}URL: https://www.benzinga.com/insights/movers/25/03/44477649/12-health-care-stocks-moving-in-tuesdays-intraday-sessionGainers Tenon Medical TNON stock rose 300.3% to $3.92 during Tuesday's regular session. The market value of their outstanding shares is at $12.2 million. As per the press release, Q4 earnings came out 3 days ago. Predictive Oncology POAI stock rose 72.19% to $1.92. The company's market cap stands at $13.8 million. ProPhase Labs PRPH stock rose 31.6% to $0.56. The market value of their outstanding shares is at $17.0 million. Forte Biosciences FBRX shares increased by 25.71% to $7.95. The market value of their outstanding shares is at $50.7 million. IO Biotech IOBT stock

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

ZYBT_OUT_11 [2025-03-25 13:48:57 -0400] 1038 Bytes | 317 tokens | Cum: 1681 tkns (21.01% of 8k)
==========================================================================

Showing A1 (chunk 2 of 3): increased by 24.61% to $1.25. The company's market cap stands at $82.1 million. Zhengye Biotechnology ZYBT shares rose 21.55% to $7.05. The market value of their outstanding shares is at $334.1 million. Losers CNS Pharma CNSP stock declined by 59.8% to $1.36 during Tuesday's regular session. The market value of their outstanding shares is at $2.0 million. Mural Oncology MURA shares declined by 59.27% to $1.56. The company's market cap stands at $26.8 million. IMAC Hldgs BACK shares declined by 59.05% to $0.17. Cormedix CRMD shares decreased by 33.8% to $7.13. The company's market cap stands at $432.6 million. The company's, Q4 earnings came out today. Cassava Sciences SAVA stock decreased by 32.33% to $1.9. The market value of their outstanding shares is at $91.1 million. Galecto GLTO stock decreased by 23.88% to $5.1. The company's market cap stands at $6.6 million. The company's, Q4 e

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

ZYBT_OUT_13 [2025-03-25 13:48:59 -0400] 267 Bytes | 67 tokens | Cum: 1750 tkns (21.88% of 8k)
==========================================================================

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

ZYBT_OUT_15 [2025-03-25 13:49:01 -0400] 193 Bytes | 60 tokens | Cum: 1812 tkns (22.65% of 8k)
==========================================================================

Showing B1 (chunk 1 of 1): B1:
Document B1 not found. Only 0 articles available.

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

ZYBT_OUT_17 [2025-03-25 13:49:02 -0400] 238 Bytes | 59 tokens | Cum: 1887 tkns (23.59% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

ZYBT_OUT_19 [2025-03-25 13:49:05 -0400] 175 Bytes | 56 tokens | Cum: 1945 tkns (24.31% of 8k)
==========================================================================

Showing S1 (chunk 1 of 1): S1:
No SEC filing available for S1.

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

ZYBT_OUT_21 [2025-03-25 13:49:19 -0400] 3271 Bytes | 813 tokens | Cum: 2781 tkns (34.76% of 8k)
==========================================================================

This is our set of metrics.
Please analyze the numbers.

+---------------------+--------------------+----------------------+-----------------------+------------------------+-------------------+
| Volume: 1,132,455 | SMA50: 63.41% | Market Cap: 351.63M | Option/Short: No / No | Sales past 5Y: -3.13% | Sales Surprise: - |
+---------------------+--------------------+----------------------+-----------------------+------------------------+-------------------+
| Avg Volume: 132.98K | SMA200: 63.17% | Shs Outstand: 47.17M | Short Float: - | Employees: 275 | EPS Surprise: - |
+---------------------+--------------------+----------------------+-----------------------+------------------------+-------------------+
| Rel Volume: 13.27 | Perf Week: 59.57% | Shs Float: - | Short Ratio: 0.26 | Debt/Eq: 0.31 | P/E: 124.71 |
+---------------------+--------------------+----------------------+-----------------------+------------------------+-------------------+
| RSI (14): 79.45 | Perf Month: 67.49% | Inst Own: - | Short Interest: 0.03M | Sales Y/Y TTM: -28.00% | Earnings: - |
+---------------------+--------------------+----------------------+-----------------------+------------------------+-------------------+
| ATR (14): 0.59 | Perf Quarter: - | Insider Own: - | Beta: - | ROE: 7.51% | |
+---------------------+--------------------+----------------------+-----------------------+------------------------+-------------------+
| SMA20: 60.00% | Index: - | Insider Trans: - | Sales Q/Q: -21.95% | ROI: 7.24% | |
+---------------------+--------------------+----------------------+-----------------------+------------------------+-------------------+

The next section covers any insider trading.
If this section may be blank due to no recent filings.

[Company Financial Summary]
[Company Details]
Name: Zhengye Biotechnology Holding Limited Ordinary Shares
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): N/A
Net Income: N/A
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 7.88
Average Volume: 131958.5
30-Day High: 7.88
30-Day Low: 4.03
No detailed financial data available.
==== END OF FINANCIAL REPORT ====

You are now requested to make a summary analysis.
Save explaining why you didn't have enough information for the final survey.

Now, complete this report with the following:

1) Brief Summary: explain your findings in succinct wording.
2) MARKET_SCORE: If you calculate a 92% likelihood of an upward moves, say: MARKET_SCORE[92]
3) PRICE_TARGET: If you think the high today will be 50% higher, add to the price.
Eg., If the current price is $5.00, add 50%. Thus, PRICE_TARGET[$7.50] -- It should be at or above the current price.
4) Provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-12 words headline for news story, distilled from summary]

1) Brief Summary, 2) MARKET_SCORE, 3) PRICE_TARGET, and 4) AI_RPT_HEADLINE

ZYBT_OUT_23 [2025-03-25 13:49:22 -0400] 676 Bytes | 167 tokens | Cum: 3195 tkns (39.94% of 8k)
==========================================================================

Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes
-> X3 <- More SEC Insider Trading (Form 3, 4, 5) Direct buys/sells from executives and institutions
-> X4 <- Broader sector & market news
-> X5 <- Your past analysis on similar companies (specify metrics)
-> X6 <- More financial metrics
-> X7 <- Your past analysis on this exact company
-> X8 <- Something altogether different (explain...)

ZYBT_IN_25 [2025-03-25 13:49:22 -0400] 126 Bytes | 29 tokens | Cum: 3252 tkns (40.65% of 8k)
==========================================================================

====================================
[2025-03-25 10:49:22] # Analysis Completed
Elapsed Time: 35.27 seconds